Ping Li, Ph.D.

Ping Li, Ph.D.

Senior Director, Protein Sciences

Ping Li brings to Celsius more than 30 years of pharmaceutical research and development experience. Prior to joining Celsius in 2017, she spent 17 years with Millennium Pharmaceuticals and Takeda with increasing responsibilities. In her most recent role as head of biologics protein sciences, she managed a diverse set of functionalities including antibody discovery/engineering, biologics analytics, molecular biology, protein expression and characterization, antibody manufactural cell-line characterization, protein mass spectrometry and cell line engineering. Ping was a member of both the Oncology Drug Discovery Management Team and the biotherapeutics senior staff. She contributed to the discovery and selection of candidate antibodies for ADC therapeutics, evaluation of in-licensing candidates, and development of manufactural cell lines for Entyvio. Before that, Ping was a senior scientist in the biotherapeutic department of BASF Bioresearch (now AbbVie), where she was responsible for recombinant protein expression and generation of transgenic mice models.

Ping completed her postdoctoral training at the Dana-Farber Cancer Institute and obtained her Ph.D. in molecular biology and genetics from Temple University.